Stockreport

Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke

Abbott Laboratories  (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
PDF ABBOTT PARK, Ill., Feb. 3, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved a new trial designed to [Read more]